Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases... Show more
A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with RPRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then RPRX could also see price increases.
| Ticker / NAME | Correlation To RIGL | 1D Price Change % | ||
|---|---|---|---|---|
| RIGL | 100% | -3.42% | ||
| RPRX - RIGL | 41% Loosely correlated | -2.09% | ||
| SRPT - RIGL | 38% Loosely correlated | -5.33% | ||
| ACAD - RIGL | 37% Loosely correlated | -4.07% | ||
| VRTX - RIGL | 36% Loosely correlated | -4.30% | ||
| INCY - RIGL | 35% Loosely correlated | -2.46% | ||
More | ||||
a clinical-stage drug development company that discovers and develops novel, small-molecule drugs
Industry Biotechnology
RIGL saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 30, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 36 instances where the indicator turned negative. In 32 of the 36 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 89%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 59 cases where RIGL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 80%.
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RIGL as a result. In 64 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RIGL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where RIGL advanced for three days, in 225 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
RIGL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 141 of 193 cases where RIGL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
The Tickeron SMR rating for this company is 12 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. RIGL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.167) is normal, around the industry mean (26.782). P/E Ratio (2.922) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (3.146) is also within normal values, averaging (437.542).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 81 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RIGL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.